Maverick Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics.
Digital HealthHealthtechMental HealthPhiladelphia, US
Justin Bekelman(Executive Officer, Director)inJonathan Rhodes(Founder)inPaul Dufault(Executive Officer)Roy Beveridge(Director)
BoardKelsey Maguire(Director)
Board seatAmbar Bhattacharyya· per SEC Form D
Co-investorsBlue Venture FundsHealthier CapitalOncology VenturesYosemite
San Francisco, US
Steve Bence(Executive Officer, Director)Alon Krashinsky(Executive Officer, Director)
BoardJosh Flum(Director)inAndy Mauer(Director)
Board seatAmbar Bhattacharyya· per SEC Form D
Co-investorsLRVHealth
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOrange County, US
Alaina Brinley Rajagopal, MD PhD(Founder)inAditya Rajagopal(Co-founder & CEO)Alaina Brinley Rajagopal(Co-founder & CMO)Yaser Abu-Mostafa(Co-founder)Lynne Rollins(Chief Financial Officer)Raymond Jimenez(Chief Technology Officer)
Co-investorsBold Capital PartnersCatalyst Health VenturesFREEFLOWWavemaker Three-Sixty Health
HealthtechWeston, US
Benjamin Schecter(Executive Officer, Director)
BoardLexi Henkel(Director)
Co-investorsSpice Capital
Wild Moose builds an AI-powered on-call copilot that automates root cause analysis for production incidents, designed for engineering teams in fast-moving environments.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSNew York City, US
Yasmin Dunsky(Founder)inRoei Schuster(Founder)inTom Tytunovich(Founder)
Co-investorsY CombinatorF2 Venture CapitaliAngels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.